The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, announced today that it has entered into a strategic global research collaboration and licensing ...